Article
Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Jan 2000
Szlendak Urszula, Lipniacka Agnieszka, Bianketti Jolanta, Podolak-Dawidziak Maria, Bykowska Ksenia
Abstract excerpt
BACKGROUND: Acute intermittent porphyria (AIP) is an metabolic disorder characterized by a partial deficiency of the porphobilinogen deaminase, the enzyme of heme biosynthesis. The metabolic defect in AIP involves an approximately half-normal activity of porphobilinogen deaminase (PBGD, EC 4.3.1.8), the enzyme catalyzing condensation of four porphobilinogen molecules to hydroxymethylbilane. Due to tissue-specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
